Table 2.
Key design feature comparison between countries
| Ethiopia | South Africa | |
|---|---|---|
| Study population – index patients | Clinically diagnosed and bacteriologically confirmed pulmonary TB patients | Bacteriologically confirmed pulmonary TB patients |
| Study population – child contacts | Children < 15 years of age | Children < 5 years of Age |
| TPT regimena |
3HP for those 3 2 years 3RH for those < 2 years 6H for those on ART |
3RH for those 0-5 years 6H for those on ART |
| Community-based care model | Health extension worker based at health post in the community | Outreach team leader (professional nurse) teamed with community health worker |
| TPT initiation and follow-up |
Performed by health extension worker; Task-shared with clinic TB focal person |
Performed by professional nurse; Task-shifted from clinic TB focal nurse to a community-based health nurse |
| Persons responsible for TPT initiation and follow-up during trial | Utilized health system’s TB focal persons and health extension workers | Research nurse and clinic’s TB focal person |
| HIV testing | Not performed at household visits | Performed at household visits |
a3HP is 12 weekly doses of rifapentine and isoniazid; 3RH is 3 months of daily rifampicin and isoniazid; 6H is 6 months of daily isoniazid